SCHEMBL6181695

SCHEMBL6181695

[CH2]C(OCC1CCC1)OCC1CCC1

nearest known ligand 0.42

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
SLC1A3 P43003 6/20 0.42
SLC1A2 P43004 6/20 0.42
SLC1A1 P43005 6/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6177405 0.89 SLC1A3 (0.39) SLC1A3SLC1A2SLC1A1
SCHEMBL127026 0.80
SCHEMBL10136484 0.79
SCHEMBL131462 0.77 SLC1A3 (0.38) SLC1A3SLC1A2SLC1A1
SCHEMBL2369591 0.74
SCHEMBL11965851 0.74 SLC1A3 (0.42) SLC1A3SLC1A2SLC1A1
SCHEMBL11225908 0.72 SLC1A3 (0.44) SLC1A3SLC1A2SLC1A1
SCHEMBL10274539 0.72 SLC1A3 (0.44) SLC1A3SLC1A2SLC1A1
SCHEMBL130749 0.72 SLC1A3 (0.38) SLC1A3SLC1A2SLC1A1
SCHEMBL23917983 0.70 SLC1A3 (0.36) SLC1A3SLC1A2SLC1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0945445-B9 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARM CO LTD (JP) 2005-12-28 EP disclosed
EP-0945445-B1 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARM CO LTD (JP) 2003-09-03 EP disclosed
US-6239131-B1 WHICH HAVE GASTRIN AND/OR CCK-B (CHOLECYSTOKININ-B) RECEPTOR ANTAGONISM, USEFUL AS REMEDIES FOR GASTRIC ULCER AND GASTROINTESTINAL MOVEMENT DISORDER. ZERIA PHARMACEUTICAL CO., LTD. (JP) 2001-05-29 US disclosed
EP-0945445-A1 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARMACEUTICAL CO., LTD. (JP) 1999-09-29 EP disclosed